Table 5.
Markers | Group | 1 day | 7 days | 14 days |
---|---|---|---|---|
TNF-α (pg/mL) | Control | 38.15 ± 22.34 | 10.97 ± 8.31 | 14.52 ± 4.88 |
Low | 12.83 ± 7.88 | 34.27 ± 3.25 | 12.31 ± 3.82 | |
High | 18.88 ± 6.02 | 34.62 ± 6.77 | 11.96 ± 4.97 | |
| ||||
IL-1β (pg/mL) | Control | 12.23 ± 2.56 | 9.96 ± 1.63 | 16.69 ± 9.10 |
Low | 9.75 ± 1.24 | 9.93 ± 1.36 | 7.13 ± 0.93 | |
High | 13.35 ± 2.79 | 18.84 ± 9.63 | 5.86 ± 2.06 | |
| ||||
IL-18 (pg/mL) | Control | 127.44 ± 59.87 | 127.56 ± 65.09 | 151.64 ± 26.23 |
Low | 154.71 ± 76.44 | 323.24 ± 29.42 | 149.90 ± 38.64 | |
High | 177.68 ± 59.95 | 361.68 ± 61.31b | 126.06 ± 40.95 | |
| ||||
G-CSF (pg/mL) | Control | 1.43 ± 0.36 | 1.52 ± 0.51 | 1.44 ± 0.20 |
Low | 1.33 ± 0.40 | 3.02 ± 0.40 | 1.56 ± 0.29 | |
High | 1.76 ± 0.46 | 3.05 ± 0.54 | 1.24 ± 0.31 | |
| ||||
M-CSF (pg/mL) | Control | 4.78 ± 0.70 | 4.61 ± 1.53 | 4.04 ± 0.60 |
Low | 4.04 ± 0.89 | 6.06 ± 0.41 | 4.05 ± 0.22 | |
High | 6.38 ± 1.08 | 7.78 ± 1.58 | 2.83 ± 0.72 | |
| ||||
VEGF (pg/mL) | Control | 311.18 ± 53.55 | 330.28 ± 49.59 | 348.50 ± 63.75 |
Low | 361.76 ± 40.87 | 379.78 ± 66.06 | 422.10 ± 82.85 | |
High | 294.94 ± 49.84 | 464.30 ± 39.59 | 319.20 ± 16.98 | |
| ||||
TGF-β1 (pg/mL) | Control | 7.64 ± 2.42 | 5.07 ± 1.63 | 11.26 ± 1.71 |
Low | 10.00 ± 2.40 | 9.93 ± 1.36 | 9.54 ± 2.56 | |
High | 8.50 ± 0.82 | 14.79 ± 9.63b | 12.77 ± 2.94 | |
| ||||
MMP-9 (ng/mL) | Control | 18.92 ± 1.43 | 25.18 ± 7.14 | 24.79 ± 5.58 |
Low | 17.99 ± 0.57 | 13.49 ± 3.35 | 36.98 ± 18.02 | |
High | 97.63 ± 27.91a | 34.94 ± 6.91 | 24.54 ± 7.31 | |
| ||||
TIMP-1 (pg/mL) | Control | 660.90 ± 91.26 | 686.85 ± 74.24 | 582.19 ± 78.56 |
Low | 688.04 ± 11.60 | 711.33 ± 52.30 | 580.34 ± 86.26 | |
High | 1,037.93 ± 156.37 | 725.42 ± 115.16 | 663.89 ± 92.97 |
Mean ± SE.
aSignificantly high versus control and low (p < 0.05).
bSignificantly high versus control (p < 0.05).